Raymond James Initiates Milestone Pharmaceuticals with Strong Buy Rating

요약

“Raymond James initiated coverage on Milestone Pharmaceuticals with a Strong Buy rating and $6.00 price target”
“The target represents nearly 200% upside from current stock price of $2.02”
“Analyst believes Cardamyst has strong potential in treating PSVT despite market skepticism”

Profit ▼ Debt high Cash good Valuation neutral Drawdown high Recent recovery

Raymond James, Milestone Pharmaceuticals에 강력 매수 평가 개시
Raymond James가 Milestone Pharmaceuticals에 강력 매수 평가와 $6.00 목표주가를 제시
현재 주가 $2.02 대비 약 200% 상승 여력 반영
시장의 회의론에도 Cardamyst의 PSVT 치료 잠재력 크다고 분석

출처: Investing.com
링크: https://www.investing.com/news/analyst-ratings/raymond-james-initiates-milestone-pharmaceuticals-stock-coverage-with-strong-buy-93CH-4606828

소셜 공유 미리보기(OG) 전용 페이지입니다.